InBody Co.,Ltd (KOSDAQ:041830)

South Korea flag South Korea · Delayed Price · Currency is KRW
32,000
-1,500 (-4.48%)
At close: Feb 27, 2026
Market Cap390.15B +25.5%
Revenue (ttm)226.62B +18.5%
Net Income32.83B +3.2%
EPS2,626.56 +7.6%
Shares Out12.19M
PE Ratio12.18
Forward PE10.82
Dividend400.00 (1.25%)
Ex-Dividend DateMar 30, 2026
Volume67,050
Average Volume41,606
Open33,150
Previous Close33,500
Day's Range31,450 - 33,450
52-Week Range21,400 - 36,000
Beta0.40
RSI43.36
Earnings DateFeb 20, 2026

About InBody Co.,Ltd

InBody Co.,Ltd provides body composition analysis solutions worldwide. It offers body composition analyzers, automatic blood pressure monitors, stadiometers, and body water analyzers, as well as InBody dial and bands. The company was formerly known as Biospace Co., Ltd. InBody Co.,Ltd was founded in 1996 and is headquartered in Seoul, South Korea. [Read more]

Industry Medical - Specialties
Sector Healthcare
Founded 1996
Employees 342
Stock Exchange KOSDAQ
Ticker Symbol 041830
Full Company Profile

Financial Performance

In 2024, InBody Co.,Ltd's revenue was 204.46 billion, an increase of 20.03% compared to the previous year's 170.35 billion. Earnings were 33.14 billion, a decrease of -9.75%.

Financial Statements